We are inspired by drugs that revolutionized the care of life-threatening human diseases, which our animal companions still suffer from.

Focusing on mechanisms with the most success in humans allows us to minimize the business and biological risks associated with bringing safe, cost-effective veterinary medicines to market.

Leveraging data science at every step is what helps us effectively translate human pharma blockbusters into veterinary therapeutics that are tailored to each species.

We build comprehensive databases of biologic therapies and animal species. Machine learning models ensure the safety and efficacy of our drug candidates, and our business plan.

Animals have long been exploited for human pharmaceuticals. We think it’s time to pay them back, by ushering in a higher standard of both research and care.

Veterinary drug approval benefits from a friendlier regulatory landscape. Our drugs are researched and developed without harming any animal species, including rodents.

Our partnerships are helping us build a sustainable business model and a best-in-class asset portfolio, including a platform capable of rapid antibody drug D&D for different species.

We believe that applying the best biotech and ML/AI driving human therapeutic innovation to animal health first can be mutually beneficial for people, their companions, and the pharmaceutical industry.

Become an Investor